What it is

Synthetic thymosin beta-4 analog studied for tissue repair and actin-cytoskeleton research.

Also known as

Thymosin Beta-4 fragment · TB4 · Thymosin beta-4 analog

Overview

TB-500 is a synthetic analog related to thymosin beta-4, studied for actin-cytoskeleton dynamics and tissue-repair research. Literature links the parent peptide family to cell migration, inflammation modulation, and wound-healing endpoints in laboratory models.

Catalogs often pair it with BPC-157 in multi-peptide repair designs; each remains a distinct research tool. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Actin-cytoskeleton and cell-migration endpoints

• • Soft-tissue repair markers in injury models

• • Inflammation-modulation readouts in recovery research

• • Wound-healing and angiogenesis-adjacent measures

• • Muscle and connective-tissue recovery markers where studied

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2: Early tissue and inflammation readouts in acute injury or repair models; compound exposure establishing.

Week 3–4: Clearer repair, angiogenesis, and mobility-adjacent markers in short research windows.

Month 2–3: More pronounced tendon/ligament/soft-tissue endpoints in extended preclinical designs.

Month 3–6: Sustained remodeling and recovery-marker observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.